麻豆传媒

Director of Cancer Screening and Survivorship, Roswell Park Cancer Institute Areas of expertise: Lung cancer, cancer screening, cancer early detection, epidemiology, cancer prevention

Dr. Rupp is a Professor in the Department of Internal Medicine, Section of Infectious Diseases at the University of Nebraska Medical Center. He is the Medical Director of The Nebraska Medical Center Department of Healthcare Epidemiology and co-Director of the Antimicrobial Stewardship Program.

Dr. Rupp received his medical degree from Baylor College of Medicine, Houston, Texas and holds a B.S. degree in Chemical Engineering from the University of Texas, Austin, Texas. He underwent internship and residency training in Internal Medicine at Virginia Commonwealth University and completed a Fellowship in Infectious Diseases at VCU.

He is a Diplomate, American Board of Internal Medicine, and in the subspecialty area of Infectious Diseases. He is a Fellow of the Society for Hospital Epidemiology of America (SHEA), American College of Physicians (ACP), and the Infectious Diseases Society of America (IDSA). He is a Past-President of SHEA and is a past-president of ASM Division L (Infection Control/Hospital Epidemiology). Dr Rupp has served as a consultant for the US Food and Drug Administration as well as the Centers for Disease Control and Prevention.

Dr. Rupp has published over 300 articles, chapters and abstracts and is the editor of a textbook entitled 鈥淏iofilms, Infections, and Antimicrobial Therapy.鈥� He frequently presents papers at national and international meetings, serves as a guest lecturer, and is an active teacher and researcher. Dr. Rupp鈥檚 research interests are in the areas of staphylococcal disease, healthcare-associated infections, and antimicrobial resistance.

Jennifer Horney is Professor and Founding Director of the Program in Epidemiology and Core Faculty at the Disaster Research Center at the University of Delaware. Her research focuses on measuring the health impacts of disasters, as well as the linkages between disaster planning and household actions related to preparedness, response, and recovery.
Dr. Horney received her Ph.D. and MPH from the University of North Carolina at Chapel Hill, where her research focused on the role of social factors in decision making during disasters. She has served on a number of national committees and is currently a member of the Board of Scientific Counselors for the Centers for Disease Control and Prevention's Center for Preparedness and Response, a member of the National Academies of Sciences, Engineering, and Medicine's Planning Committee on Exploring Best Practices in Integration of Public Health and Human Services Service Delivery and Assessment Following Large Scale Disasters, and a member of the Publications Board of the American Public Health Association. She has led interdisciplinary research projects funded by the National Institute for Environmental Health Sciences, National Science Foundation, National Oceanic and Atmospheric Administration, the National Academies of Sciences, the Department of Homeland Security and other federal, state, and local agencies.
Dr. Horney was a member of a team of public health practitioners who responded to Hurricanes Isabel, Charley, Katrina, Wilma, Irene, and Harvey where she conducted rapid assessments of disaster impact on the public health of individuals and communities. She has also provided technical assistance to public health agencies globally around disasters, emerging infectious disease outbreaks, and pandemic influenza planning and response.

Larry K. Kociolek, MD is an Attending Physician, Infectious Diseases; Associate Medical Director, Infection Prevention and Control; Irene Heinz Given and John La Porte Given Professorship in Pediatrics and Assistant Professor of Pediatrics, Northwestern University Feinberg School of Medicine. 

With interest in the areas of healthcare epidemiology and infection prevention and control, particularly Clostridium difficile infections, infections caused by antibiotic-resistant bacteria, infections in immunocompromised children, Kawasaki Disease. Other areas of investigation include the use of whole-genome sequencing to assess antibiotic resistance determinants and virulence factors of emerging strains of C. difficile, namely DH/NAP11/106, as well as identifying transmission and evolution of C. difficile clones in a pediatric population.

Shandy Dearth has spent most of her career focusing on infectious disease surveillance, emergency preparedness planning and response, and public health informatics. Prior to joining the FSPH, she was the Director of an international public health association that brought together public health practitioners and public health researchers who focused on health data surveillance projects. Prior to her work with the non-profit, Ms. Dearth was the Administrator in the Epidemiology Department of a local health department. She is currently a member of her community's park advisory council and is a proponent of advocating for more public health resources in Indiana.

Dr. Ostrosky-Zeichner is a professor of medicine and epidemiology, the chair of the Division of Infectious Diseases, the Vice-Chair of Medicine for Healthcare Quality, and the director of the Laboratory of Mycology Research, at McGovern Medical School (a part of UTHealth Houston). He also serves medical director for epidemiology and antimicrobial stewardship for Memorial Hermann Texas Medical Center and UT Physicians. He also coordinated the CoVID-19 response for UTHealth and its affiliated hospitals and clinics. Dr. Ostrosky-Zeichner obtained his medical degree from Universidad Nacional Autonoma de Mexico. He completed his internal medicine residency at Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, and his infectious diseases fellowship at the University of Texas Medical School at Houston and MD Anderson Cancer Center combined fellowship program. Dr. Ostrosky-Zeichner is a fellow of the American College of Physicians, the Infectious Diseases Society of America, the Society of Healthcare Epidemiology of America, and the Academy of the European Confederation of Medical Mycology. He is a Senior Editor for the Journal of Antimicrobial Chemotherapy, as well as an editorial board member of Antimicrobial Agents and Chemotherapy and Clinical Infectious Diseases. He is Vice President of the Mycoses Study Group and Educational Consortium and a Board Member of the International Immunocompromised Host Society. He is also a past chair of the Infectious Diseases Society of America Standards and Practice Guidelines Committee and has been a consultant to the US FDA and CDC. He has advanced training and experience in medical mycology, healthcare epidemiology, emerging infections, antimicrobial stewardship, general and transplant infectious diseases, and healthcare quality and has published over 155 peer-reviewed articles on those topics.

Cathy Troisi is a professor in the Divisions of Management, Policy, and Community Health and Epidemiology at UTHealth Houston School of Public Health and coordinator for the Leadership Studies Concentration. She teaches courses in leadership and public health and is a faculty advisor for the Society for Women and Leadership. She created and manages the undergraduate public health certificate program. Her research interests are in infectious disease epidemiology, and she has research grants in the areas of HIV, viral hepatitis, and improving immunization rates. She holds a BA in Chemistry from the University of Rochester, an MS in Biochemistry from Michigan State University, and a Ph.D. in Epidemiologic Sciences from the University of Michigan. She completed the National Public Health Leadership Training in February 2011. Previously, she served at the Houston Department of Health and Human Services, where she worked on policy development, research collaborations with academic institutions, promotion of public health education for staff, and preparing for health department accreditation. Prior to that, Cathy was assistant director for the Division of Disease Prevention and Control and prior to that, bureau chief for HIV/STD prevention. Prior to joining HDHHS, she was on the faculty of UTHealth and Baylor College of Medicine. Having experience in both academia and practice, her passion, besides infectious diseases, is bridging the gap between these two essential components of public health. Cathy has been involved with APHA since 2004. She is active in the Epidemiology Section and served as programming chair for two years and Epidemiology Section representative to the Governing Council for seven years. She served as chair of the APHA Action Board and co-chair of the Joint Policy Committee. In the past three years, she has had 15 op-eds published in Texas newspapers and given over 100 media interviews on public health issues. Cathy received the APHA Advocacy award in 2015. She is active with the Texas Affiliate as well, having served on the governing council, and receiving the TPHA award for outstanding service in 2010. She is a member of the National Association of County and City Health Officials epidemiology workgroup as well as many local and state public health advisory boards. 

Lauren Ancel Meyers is the Cooley Centennial Professor of Integrative Biology and Statistics & Data Sciences at The University of Texas at Austin and a member of the Santa Fe Institute External Faculty. She was trained as a mathematical biologist at Harvard and Stanford Universities and has been a pioneer in the field of network epidemiology and the application of machine learning to improve outbreak detection, forecasting and control.

Professor Meyers leads an interdisciplinary team of scientists, engineers, and public health experts in uncovering the social and biological drivers of epidemics and building practical tools for the CDC and other global health agencies to track and mitigate emerging viral threats, including COVID-19, pandemic influenza, Ebola, HIV, and Zika. Her research has been published in over 100 peer-reviewed articles in major journals and covered by the popular press, including The Wall Street Journal, New York Times, Washington Post, NPR, CNN and the BBC. Professor Meyers was named as one of the top 100 global innovators under age 35 by the MIT Technology Review in 2004 and received the Joseph Lieberman Award for Significant Contributions to Science in 2017.

Awards & Fellowships

2018- Denton A. Cooley Centennial Professorship, UT
2017 Joseph Lieberman Award for Significant Contributions to Science
2011-2013, 16-18 William H. and Gladys G. Reeder Faculty Fellow, UT
2006-2010, 14-15 Fellow, University of Texas Institute for Molecular and Cellular Biology
2013 Center for Excellence in Education - Excellence and Achievement Award
2010-2011 Donald D. Harrington Faculty Fellowship, UT
2005 College of Natural Sciences Teaching Excellence Award, University of Texas
2004 MIT Technology Review TR100: One of 100 Top Global Innovators Under 35
2000-2002 National Science Foundation Postdoctoral Fellowship in Biological Informatics
2000-2002 Santa Fe Institute Postdoctoral Fellowship
2000 Samuel Karlin Prize for Ph.D Thesis in Mathematical Biology
1999 Steinmetz Fellowship, Santa Fe Institute
1996-1999 National Defense Science & Engineering Graduate Fellowship
1991-1995 U.S. Congressional National Science Scholar

Spencer J. Fox is Associate Director of The University of Texas at Austin COVID-19 Modeling Consortium and a research associate at UT Austin. His expertise is in statistical modeling of infectious diseases and machine learning, and his research focuses on understanding emerging infectious diseases and pandemics, as well as developing response tools for public health officials. He earned his undergraduate degree in Biology at Rose-Hulman Institute of Technology and received a doctoral degree in Integrative Biology from the University of Texas at Austin in 2018, working with Professor Lauren Ancel Meyers. 

 

Fellowships & Awards

National Geographic Young Explorer (2017)

UT Austin recruitment fellowship (2013)

Dr. Linas is a national leader in hepatitis-C virus (HCV) infection and HCV/HIV co-infection comparative- and cost-effectiveness research using computational biology, clinical epidemiology and clinical economics methods. Dr. Linas has an excellent track record of productivity, ample funding from the NIH and CDC, and a growing core of successful trainees. Dr. Linas directs the HIV/HCV core of the Center for Health Economics of Treatment Interventions for Substance Use Disorders, HCV, and HIV, funded by the National Institute on Drug Abuse (NIDA) in collaboration with Cornell, U Penn and Miami.

Dr. Stibich is an infectious diseases epidemiologist, founder and Chief Scientific Officer for Xenex Disinfection Services, the world leader in UV disinfection for healthcare facilities. Xenex's LightStrike Germ-Zapping Robots are used by hundreds of healthcare facilities (and now office buildings, schools, professional sports teams, hotels, police stations, correctional facilities, airports and convention centers) to reduce the microbial contamination from "superbugs" such as MRSA, VRE and C. diff. The LightStrike robot is proven to deactivate SARS-CoV-2 (the virus that causes COVID-19) in 2 minutes. More than 40 peer-reviewed studies documenting the robot's efficacy have been published in scientific journals. 

Dr. Stibich specializes in creating efficient solutions for public health problems. He received his doctoral training from the Johns Hopkins School of Public Health and has been involved in numerous international research and intervention projects. He is an inventor on over 125 patents relating to infection prevention, a principal investigator on an NIH grant, and was a visiting scientist at MD Anderson Cancer Center.

A Fellow of the Infectious Diseases Society of America and a Fellow with the Royal Society of Medicine, Dr. Stibich  is a frequent speaker and has presented for many organizations including TEDx, DENT and the Royal Society of Medicine.   

Dr. Bell鈥檚 research interests include examining the association of environmental exposures and adverse birth and child health outcomes, including neurodevelopment. She is particularly interested in the relationship between social factors and environmental exposures and their combined impact on child development. Dr. Bell most recently served as co-Principal Investigator of the Upstate KIDS study, a cohort study of over 6000 infants designed to examine risk factors for development differences, Autism and additional growth and developmental outcomes.

Currently, she is the co-Principal Investigator with the New York State Department of Health, of a cohort study to recruit and enroll participants into a prospective cohort of adults and children to examine the long-term health effects associated with consumption of drinking water contaminated with per and poly alkyl substances (PFAS).  She previously led the investigations of adverse reproductive outcomes by levels of air pollutants in the New York State Department of Health鈥檚 Environmental Health Tracking Program and previously served as a co-PI of the New York Center for the National Birth Defects Prevention Study/BD-STEPS multi-center studies funded by the Centers for Disease Prevention and Control (CDC).

Given the strong correlation between excess exposure to environmental contaminants, poverty and racial inequalities, her research and community service have more recently expanded into exploring the health outcomes related to these disparities. She currently serves on the executive committee of the Center for Social and Demographic Analysis and as a member of the Community Advisory Board for the Ezra Prentice neighborhood, an Environmental Justice Community in Albany, NY. She has previously served as a member on three of the Institute of Medicine Committees on Review of the Health Effects in Vietnam Veterans of Exposure to Herbicides. Currently, she is a member of the National Academy of Medicine's Committee on Guidance on PFAS Testing and Health Outcomes.

Beth J Feingold, PhD is an interdisciplinary environmental health scientist. Bridging geography, epidemiology and global health, her research addresses the dynamic relationship among the food system, environmental sustainability and population health.

Dr. Feingold earned her PhD in Public Health from the Johns Hopkins Bloomberg School of Public Health, her Master of Environmental Science from the Yale School of Forestry and Environmental Studies, her Master of Public Health from Yale School of Public Health and her Bachelor of Arts in Geology from Vassar College. She was the Glenadore and Howard L Pim Postdoctoral Fellow in the Department of Earth and Planetary Sciences at Johns Hopkins University and a Postdoctoral Associate at Duke University鈥檚 Nicholas School of the Environment and Global Health Institute. She joined the University at Albany as an Assistant Professor in 2014.

 

Research interests
Anthropogenic (human-induced) changes to the environment affect and are affected by food production and consumption; this, in turn, impacts nutrition and human health. Dr. Feingold addresses these relationships locally, nationally and internationally by utilizing novel assessment tools and engaging communities. Her three main themes of research are:

Assessing dietary and environmental drivers of disease risk in regions undergoing large-scale anthropogenic change 
Environmental, nutritional and health impacts of wasted food recovery & redistribution
Impacts of large-scale agriculture on human health.

Specialization: Health Policy

Erika Martin is a Professor of Public Administration and Policy. She is a faculty affiliate in the Department of Health Policy, Management & Behavior, the Center for Collaborative HIV Research in Practice and Policy, and the Center for Technology in Government. Her research focuses on infectious disease policies and programs, the allocation of scarce public health resources, the adoption and impact of public health policies, public health infrastructure and data systems, and translating evidence-based research into practice. She applies diverse research approaches, including program evaluation, modeling, analysis of administrative and survey data, key informant interviews, and economic analysis.

She directs the Coalition for Applied Modeling and Prevention (CAMP), a multi-institution consortium funded by the Centers for Disease Control and Prevention. CAMP is dedicated to creating models that improve public health decision-making at the national, state, and local levels in the areas of HIV, viral hepatitis, sexually transmitted infections, tuberculosis, and school/adolescent health. For more information, please visit the CAMP website.

At Rockefeller College, she teaches courses on research design and program evaluation.

Dr. Cary Gross is a Professor of Medicine and Public Health, and Director of the National Clinician Scholars Program at Yale. Dr. Gross completed his residency in Internal Medicine at New York Hospital-Cornell Medical Center and served as chief medical resident at Memorial Sloan-Kettering Cancer Center the following year. His research addresses comparative effectiveness, quality, and health equity, with a focus on cancer prevention and treatment. He aims to use real-world research to generate knowledge that will inform change in clinical care and health policy. He is a founding Director of Yale鈥檚 Cancer Outcomes Public Policy and Effectiveness Research Center (COPPER). His research has been supported by the National Cancer Institute, the American Cancer Society, among others. As a former Robert Wood Johnson Foundation Clinical Scholar, Dr. Gross has advanced training in biostatistics, epidemiology, research ethics, and outcomes research. Follow him on twitter: @cpgYale

Associate Professor and Assistant Dean of Strategy & Accreditation at Creighton University鈥檚 School of Medicine.
Dr. Rengua Vivekanandan, M.D., is an infectious disease expert and an award-winning physician whose research and experience positions her as a prominent voice on public health, epidemiology, gender equity in health care, organ transplant outcomes and antibiotics stewardship. Dr. Vivekanandan is also the Director of Antimicrobial Stewardship & Hospital Epidemiology at CHI Health Creighton University Medical Center 鈥� Bergan Mercy.
Dr. Vivekanandan was named a 2021 Champion of Humanistic Care Award winner by the Arnold P. Gold Foundation. She earned a Distinguished Faculty Service Award from Creighton University and received The Walter J. O鈥橠onohue, Jr. Award from the Nebraska Chapter of the American College of Physicians. She was named a 40 Under 40 Honor by the Midlands Business Journal in 2019 and she was a finalist for the Inspire: Celebrating Women鈥檚 Leadership Award for Excellence in Healthcare in 2022.
In addition to publishing numerous research papers and articles, Dr. Vivekanandan is a regular presenter at national conferences, educational webinars and professional seminars. She mentors and collaborates with medical students, residents and fellows. Dr. Vivekanandan recently served as a member of the Big East Conference鈥檚 COVID-19 Task Force to help safely guide athletic departments through the pandemic.

Associate Dean, Professor, and Department Chair of Clinical Research and Public Health at Creighton University鈥檚 School of Medicine
Dr. Maureen Tierney, M.D., M.S., is a distinguished researcher and renowned epidemiologist whose expertise covers several medical fields, including public health policy, infectious disease prevention, pathogen analysis, and health professions workplace safety.
Dr. Tierney earned the Inaugural McKnight Prize for Healthcare Outbreak Heroes in 2020 after her investigative work helped contain an infection outbreak in a hospital specialty unit. She is a member of the Infectious Disease Society of America, the Society for Healthcare Epidemiology of America, the Council of State and Territorial Epidemiologists, and the America College of Physicians. She has participated in CORHA (Council on Outbreak Response for Healthcare-Associated Infections and Antimicrobial Resistance). She has served previously as the Medical Director of the Healthcare-Associated Infections and Antimicrobial Resistance Program at Nebraska鈥檚 Department of Health and Human Services.
The principal investigator of a 2021 Centers for Disease Control-commissioned study on the impact of COVID, Dr. Tierney regularly publishes abstracts, articles, chapters, and regulatory documents to advise doctors, hospital administrators, and the general public.

, is a professor of clinical medicine in the Department of Medicine, Division of Infectious Diseases at the University of California, San Diego. She sees patients in the Owen Clinic and the infectious diseases clinic. She also cares for people during hospital stays.
Dr. Torriani is medical director of the UC San Diego Infection Prevention and Clinical Epidemiology and the tuberculosis control units at UC San Diego Health. In collaboration with Atlas Public Health, she has been instrumental in creating an extensive electronic microbiology surveillance and pharmacy utilization program called Guardian that allows for internal data mining, surveillance, unit-specific antibiogram production, and external reporting of contagious infections to San Diego Public Health and to the California Department of Public Health (CDPH) of Healthcare Associated Infections (HAI).
Since 2010, Dr. Torriani has served on the Metrics Group for CA HAI Reporting, an independent group of experts discussing best standards and methods for HAI reporting in California. 
She is fluent in five languages: Italian, French, German, Spanish and English.

Dr. Yasminka Jakubek is an assistant professor in the Division of Biomedical Informatics at the University of Kentucky and an associate member of the UK Markey Cancer Center. 
She has led and contributed to several genomic studies of tumors, pre-malignant lesions, and genetic mosaicism in pathologically normal samples. Her work includes methods developments for the study of intra-tumor heterogeneity and copy number changes. Dr. Jakubek’s research program aims to advance our understanding of the earliest stages in disease development by studying somatic mutations and clonal dynamics across tissue types.
Dr. Jakubek obtained her B.A. from Cornell University in Ithaca, NY, and her Ph.D. from Emory University in Atlanta, GA. She completed her postdoctoral training at MD Anderson Cancer Center in Houston, TX

Dr. Zhang joined UT Southwestern as an assistant professor in September, 2007. He currently serves as the director of BERD (Biostatistics, Epidemiology, and Research Design) for the UTSW CTSA program. He also serves on the NCI Central Institutional Review Board (Adult CIRB – Early Phase Emphasis). 
Dr. Zhang’s research interest in statistical methodology lies in two main areas: Bayesian hierarchical modeling and clinical trial design. He has published multiple papers on the application of Bayesian hierarchical models to disease mapping, joint modeling of longitudinal and survival outcomes, item-response theory for grant review, functional enrichment analysis to detect important pathways, and multi-level modeling to detect factors that impact cancer screening, etc. Another area of his research interest is design methodology for clinical trials to account for various pragmatic issues such as correlated outcomes (clustered and longitudinal), missing data, small sample sizes, historical control, random variability in cluster size, and cost constraints, etc. He has published multiple high quality papers in this area and in 2015 he co-authored a book titled “Sample Size Calculations on Clustered and Longitudinal Outcomes in Clinical Research” (Chapman & Hall, New York). Dr. Zhang has been successful in securing extramural grants as the PI to support his independent research program, examples include an NIH R03 grant to conduct secondary data analysis on VA HIV registry; an NSF grant to build risk prediction model based on electronic health record data; and a PCORI methodology development grant to address pragmatic design issues in stepped-wedge cluster randomized trials.